Cannvas.Me to Provide Seamless Referrals to NamasteMD
TORONTO, Dec. 4, 2018 /CNW/ - Cannvas MedTech Inc.
("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM), a leading business technology
company in the cannabis space, is pleased to report that integration of the revenue sharing partnership with Namaste
Technologies Inc. ("Namaste") (TSXV: N, FRA: M5BQ, OTCMKTS: NXTTF), a leading technology company operating the largest global
cannabis e-commerce platform, is proceeding as planned. Cannvas and Namaste are deploying technologies to drive customer
integration and value-added services between company platforms.
"As Cannvas.Me continues to serve a robust audience with unbiased educational content around the potential benefits of
cannabis as an alternative therapy, a partnership with the de facto leader in the digital cannabis space extends the reach of
both organizations and helps bring us and Namaste closer to our goals of providing Canadians with access to cannabis learning
before they choose to consume," said Steve Loutskou, Chief Operating Officer, Cannvas MedTech Inc.
"The amalgamation of Namaste's medical cannabis patient portal and our cannabis-centric education platform is expected to be
operational in a matter of weeks. The team at Namaste is exceptional and we are looking forward to the successful integration of
our Cannvas.Me platform with NamasteMD for the seamless referral of patients."
Namaste is the world's largest and most comprehensive cannabis-focused e-commerce platform with a fully-integrated e-commerce
network spanning across the globe offering everything from rolling papers to vaporizers. In Canada, Namaste has developed the country's first telemedicine app, available on iPhone and Android devices,
allowing patients to connect to doctors or nurse practitioners and have access to a wide range of high-quality cannabis products
and services.
Cannvas.Me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and
physician-backed content to audiences wishing to learn about health care through cannabis. Its mission is to place users in the
driver's seat of their health care journey, arming them with unbiased information on whether medicinal or therapeutic use of
cannabis can be beneficial to their lifestyle.
Cannvas.Me operates independently of any Licensed Producers or Clinic funding, working with its own Medical Advisory Board and
Education Advisory Panel to provide a safe space for potential and active users to learn about cannabis with no pressure to
consume or purchase.
About Namaste Technologies Inc.
Namaste Technologies is Your Everything Cannabis Store™. Namaste operates the largest global cannabis e-commerce platform with
over 30 websites in 20+ countries under various brands. Namaste's product offering through its subsidiaries includes vaporizers,
glassware, accessories, CBD products, and the company will soon be selling medical cannabis in the Canadian market, subject to
approval by Health Canada.
Namaste has developed and acquired innovative technology platforms including NamasteMD.com, an online patient portal, and in
May 2018 the Company acquired a leading e-commerce AI and Machine Learning Company, Findify AB.
Findify uses artificial intelligence algorithms to optimize and personalize a consumer's on-site buying experience. Namaste is
focused on leveraging its cutting-edge technology to enhance the user experience throughout its platforms. Namaste will continue
to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the
broader cannabis market.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric
solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business
drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy
of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that
describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a
stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature,
they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its
business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings
with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2018/04/c5664.html